Courts back NHS in fight against Novartis and Bayer
September 24, 2018Sales and Marketing Bayer, Eylea, NHS, Novartis, avastin, ludentis
The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block …
Life expectancy falls in America; drugs, alcohol and suicide to blame
September 24, 2018Sales and Marketing USA, alcohol, drugs, health, opiod crisis, suicide
Life expectancy has fallen for the second year in a row for people in the United States, according to new …
AstraZeneca’s Farxiga cuts heart risk in type 2 diabetes patients
September 24, 2018Research and Development, Sales and Marketing AstraZeneca, diabetes, farxiga, pharma
AstraZeneca has unveiled new Phase 3 data for its SGLT2 inhibitor Farxiga (dapagliflozin), showing with the drug demonstrating positive findings …
EU approval for Mylan and Fujifilm’s Humira biosimilar
September 21, 2018Medical Communications, Sales and Marketing EU, Europe, Humira, Mylan, biosimilar, pharma
The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing authorisation to …
Top Ten most popular articles on Pharmafile.com this week
September 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Novartis, Novo Nordisk, Senate, UCB, manufacturing, opioid crisis, top 10
Manufacturing took a hit this week as Novo Nordisk announced the loss of 400 jobs while Novartis made the move …
ABPI forges five year partnership with AHSN focused on increased uptake of transformative biomedical innovations into the NHS
September 21, 2018Medical Communications ABPI, NHS, UK, ahsn, collaboration
The Association of the British Pharmaceutical Industry (ABPI) has announced that it is forging a five year partnership with the …
British MPs call for HIV prevention PrEP drugs to be made available on NHS in England
September 21, 2018Medical Communications
PrEP drugs – pre-sex drugs that are able to dramatically reduce the chances a person has of contracting HIV – …
Surgeon General calls for cultural shift in approach to opioid crisis
September 21, 2018Medical Communications Trump, US, opioid crisis, opioid epidemic, surgeon general
The Surgeon General of the United States has called for a cultural shift in the way in which Americans talk …
Shares in Molecular Templates surge after the announcement of Takeda collaboration
September 20, 2018Business Services, Research and Development Molecular Templates, Shares, Takeda, markets, stocks
Shares in the Texas based biotech Molecular Templates have soared after the company announced that they would be collaborating with …
A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated
September 20, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma
Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …
Astellas’ chronic kidney drug shows superiority at Phase 3
September 20, 2018Research and Development Astellas, chronic kidney disease, pharma, roxadustat
Astellas has revealed new Phase 3 data for roxadustat in the treatment of chronic kidney disease (CKD) in patients with …
Senate bill would save money and allow generics to reach market more quickly, according to CBO report
September 20, 2018Business Services, Medical Communications, Sales and Marketing CBO, Senate, US, biosimilars, generics, law, politics
The Congressional Budget Office (CBO) has said in a report that a bipartisan bill awaiting a vote in the senate …
FDA greenlights Teva’s migraine drug Ajovy in two dosage options
September 20, 2018Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma
Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …
MSD to launch Keytruda at half US list price in China
September 20, 2018Business Services, Sales and Marketing BMS, China, MSD, global, keytruda, markets, pricing
US pharma giant MSD will offer cutting edge cancer treatment Keytruda to Chinese patients at half the price at what …
Almirall’s Ilumetri scores EU approval in chronic plaque psoriasis
September 19, 2018Research and Development, Sales and Marketing Almirall, EADV 2018, Ilumetri, pharma, psoriasis
Hot on the heels of the European Academy of Dermatology and Venereology Congress (EADV) 2018 where psoriasis took centre stage, …
NICE rejects CAR-T therapy Kymriah for DLBCL in adults
September 19, 2018Research and Development CAR T, CAR-T, Kymriah, NICE, Novartis, leukaemia
The National Institute for health and Care Excellence (NICE) has rejected Novartis’ CAR-T therapy Kymriah for use in adults with …
Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected
September 19, 2018Manufacturing and Production, Research and Development Netherlands, Novartis, amsterdam, pahrma, pharma
Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, …
AstraZeneca to increase presence in China
September 19, 2018Research and Development AstraZeneca, China, alibaba, governemnt, tencent
The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to …
FDA expand REMS education program in effort against opioid crisis
September 19, 2018Research and Development FDA, IR, opioid crisis, opioids, rems
The US Food and Drug Administration is set to introduce a requirement that all healthcare providers be offered educational training …
Cancer Research UK announces new £14m research hub in London
September 18, 2018Manufacturing and Production, Research and Development CRUK, Cancer, pharma
Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
